QBIO

Q BioMed (CE) (QBIO)

Q BioMed Inc (CE)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:QBIO

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/17	05:01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2023/05/27	05:56	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:QBIO	Q BioMed Inc (CE)
2023/03/02	03:02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:QBIO	Q BioMed Inc (CE)
2022/12/08	05:01	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:QBIO	Q BioMed Inc (CE)
2022/11/19	07:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2022/11/04	05:04	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2022/07/29	05:19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2022/07/16	06:01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2022/05/14	05:35	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2022/04/15	06:01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2022/01/26	01:33	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2022/01/12	06:36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
2021/10/16	05:19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2021/10/08	01:27	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2021/07/31	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2021/05/11	05:10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2021/04/15	06:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2021/02/27	02:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
2021/02/17	07:28	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2021/02/05	20:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
2021/01/11	20:01	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:QBIO	Q BioMed Inc (CE)
2020/12/30	03:07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
2020/11/20	05:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
2020/11/20	05:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
2020/10/15	05:58	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2020/09/15	21:53	InvestorsHub NewsWire	Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe	USOTC:QBIO	Q BioMed Inc (CE)
2020/08/26	20:30	InvestorsHub NewsWire	Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program	USOTC:QBIO	Q BioMed Inc (CE)
2020/08/11	21:05	InvestorsHub NewsWire	Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain	USOTC:QBIO	Q BioMed Inc (CE)
2020/07/16	05:58	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
2020/06/12	01:13	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:QBIO	Q BioMed Inc (CE)